Atlantis Subsea Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Atlantis Subsea Indonesia Tbk. trades at Rp50 (market cap 309.98B, 353K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Atlantis Subsea Indonesia Tbk. is the larger of the two by market cap, and Atlantis Subsea Indonesia Tbk. is more actively traded (353K versus 214.9K). Which is the better fit depends on your goals.
| ATLA | OBAT | |
|---|---|---|
Market Cap | 309.98B | 164.65B |
Volume | 353K | 214.9K |
Lot | 3.53K | 2.15K |
Turnover | 17.65M | 51.97M |
Average Price | 50 | 241.85 |
Value | 17.65M | 51.97M |
Indicative Equilibrium Price | 50 | 240 |
Indicative Equilibrium Volume | 5 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Atlantis Subsea Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 13 dated November 22, 2016 by Heri Martono, S.H. The Company started its commercial activities in 2016.
Read more on ATLA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →